Recent Updates — CDT
CDT Equity Inc. entered into an evaluation agreement with Manoira Corporation to analyze its clinical-stage compounds AZD1656 and AZD5904 to determine if they can enhance Manoira's upcoming animal healthcare product range, scheduled for launch in the first quarter of 2027. CDT issued 1,347,616 shares valued at $195,000 to settle the payment. The agreement allows Manoira to test these assets and, if successful, pursue licensing discussions. Additionally, the company issued shares for consulting services, a securities purchase agreement settlement, and executive severance. CDT Equity Inc. is a data-driven biopharmaceutical development company focused on identifying and advancing therapeutic assets through scientific innovation.
CDT Equity Inc. issued a senior secured convertible promissory note with a principal amount of $6,750,000 to lender J.J. Astor & Co., receiving net proceeds of $2,869,850 from the first tranche. The note matures on March 24, 2027, and is repaid via weekly installments. The company also issued warrants for 225,000 shares at an exercise price of $0.9177 per share. Proceeds from future equity offerings are pledged to repay the debt. CDT Equity Inc. operates in the investment and financial services sector.
CDT Equity Inc. filed a certificate of amendment with the Delaware Secretary of State to effectuate a 1-for-25 reverse stock split of its common stock, reducing outstanding shares from approximately 28 million to roughly 1,124,515. The transaction becomes effective on September 28, 2026, at 5:00 p.m. Eastern Time, with adjusted trading expected to commence on September 29, 2026. This action is taken to ensure continued compliance with Nasdaq's bid-price rule for listing maintenance. Fractional shares are not issued; instead, holders receive cash payments based on the closing price on the effective date. CDT Equity Inc. operates in the biopharmaceutical industry, focusing on data-driven drug discovery and therapeutic asset development.
On September 14, 2026, CDT Equity Inc. issued a senior secured convertible promissory note to J.J. Astor & Co. with a principal amount of $2,126,250 and net proceeds of $1,501,850. The note matures on March 1, 2027, requiring twenty-four weekly installments of $88,593.75. Concurrently, the company issued warrants to purchase 3,468,500 shares at an exercise price of $0.25 per share. Proceeds from the company's at-the-market offering program are prioritized to repay this note after satisfying a prior August note obligation. The lender may convert the debt into common stock at a conversion price equal to 70% of the lowest volume-weighted average price over the preceding twenty trading days, subject to a $0.05 floor and a 4.99% beneficial ownership limit. CDT Equity Inc. operates in the investment management industry.
CDT Equity Inc. amended its Securities Purchase Agreement with Sarborg Limited to acquire a 20% equity interest for $8,000,000. The amendment allows $1,750,000 of the consideration to be paid via common stock issuance and credits audit costs against the cash balance. CDT issued 650,000 shares to Sarborg on August 31, 2026, satisfying part of the equity portion. Remaining cash payments will come from at-the-market program proceeds, with minimum monthly payments of $150,000 and a final due date of May 31, 2027. Additionally, CDT issued a senior secured convertible promissory note to J.J. Astor & Co. for $541,620, receiving net proceeds of $375,002. The company also issued warrants to purchase 237,000 shares at an exercise price of $1.69 per share. The note was repaid in full on September 4, 2026, and no conversion shares were issued. CDT Equity Inc. operates as a holding company focused on investments in various industries.
CDT Equity Inc. appointed James Bligh as Chief Executive Officer effective August 31, 2026, with an annual base salary of $600,000 and a target bonus of 50% of base. Dr. Andrew Regan resigned as CEO and from the Board, receiving severance of $50,000 monthly for six months. The company's board size decreased to four members. At its August 28, 2026 annual meeting, shareholders approved a reverse stock split with a ratio between 1-for-2 and 1-for-100, authorized the issuance of shares under Nasdaq Listing Rule 5635 for senior secured convertible notes issued to J.J. Astor & Co., and approved the issuance of up to 12,131,770 shares upon exercise of pre-funded warrants. CDT Equity Inc. operates in the investment management industry.